UTHR PEER ANALYSIS

United Therapeutics Corporation — metric-by-metric comparison with peers and the industry median

UTHRUnited Therapeutics Corporation

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

UTHRIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	UTHR	MRK	ROVI	BHC	ECILC	GENIL	Ind. Median
P/E	20.06●	24.51	22.16	—	—	46.82	21.35
P/B	4.38	2.09	4.33	-0.87●	0.80	3.47	1.77
EV/EBITDA	—	11.78	14.69	4.05●	33.84	14.07	12.18
P/S	8.15	2.96	3.94	0.20●	5.03	1.86	2.08

Financial Health
Metric	UTHR	MRK	ROVI	BHC	ECILC	GENIL	Ind. Median
Current Ratio	4.79●	1.51	3.66	1.32	1.73	1.33	2.22
Debt/Equity	—	40.5%	17.0%	-1,010.0%●	5.9%	41.0%	46.3%
NetDebt/EBITDA	—	1.38	0.09	3.71	-0.10●	1.10	1.24

Profitability
Metric	UTHR	MRK	ROVI	BHC	ECILC	GENIL	Ind. Median
Net Margin	40.6%●	12.1%	17.8%	-13.5%	-3.6%	4.0%	4.0%
ROE	20.3%	8.5%	20.9%●	—	-0.6%	8.7%	6.4%
ROA	17.8%●	4.9%	15.1%	-4.7%	-0.5%	4.8%	3.4%
EBITDA Margin	54.1%	28.5%	27.0%	60.0%●	14.8%	14.3%	18.2%

Growth + Dividend
Metric	UTHR	MRK	ROVI	BHC	ECILC	GENIL	Ind. Median
Rev. Growth	5.9%	-1.7%	-3.4%	-9.9%	-2.3%	16.3%●	7.5%
NI Growth	6.3%	-10.1%	-5.9%	—	—	146.6%●	5.0%
Div. Yield	—	1.5%	1.6%	0.0%	2.6%●	0.0%	2.0%
Payout	—	11.8%	36.3%	0.0%	-365.1%	0.0%	0.8%

Valuation
Metric	UTHR	ZTS	VTRS	NBIX	ELAN	ALKS	Ind. Median
P/E	20.06	12.05●	—	26.92	—	60.01	21.35
P/B	4.38	9.85	1.35●	5.28	1.96	5.23	1.77
EV/EBITDA	—	9.72●	12.59	17.88	21.31	37.03	12.18
P/S	8.15	3.35	1.36●	5.80	2.60	5.87	2.08

Financial Health
Metric	UTHR	ZTS	VTRS	NBIX	ELAN	ALKS	Ind. Median
Current Ratio	4.79●	3.15	1.60	2.93	2.16	2.27	2.22
Debt/Equity	—	285.7%	97.9%	11.9%●	61.4%	90.3%	46.3%
NetDebt/EBITDA	—	1.81	4.89	-0.95●	4.66	3.87	1.24

Profitability
Metric	UTHR	ZTS	VTRS	NBIX	ELAN	ALKS	Ind. Median
Net Margin	40.6%●	27.8%	-2.0%	21.6%	-4.9%	9.8%	4.0%
ROE	20.3%	67.0%●	-2.0%	22.5%	-3.8%	9.4%	6.4%
ROA	17.8%	18.1%●	-0.8%	15.6%	-1.8%	4.8%	3.4%
EBITDA Margin	54.1%●	42.4%	17.6%	30.8%	15.6%	17.7%	18.2%

Growth + Dividend
Metric	UTHR	ZTS	VTRS	NBIX	ELAN	ALKS	Ind. Median
Rev. Growth	5.9%	2.4%	1.6%	28.6%●	10.5%	3.2%	7.5%
NI Growth	6.3%	5.0%	—	118.6%●	—	-56.7%	5.0%
Div. Yield	—	2.8%	3.0%●	—	—	—	2.0%
Payout	—	33.6%	-188.0%	—	—	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on UTHR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.